Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Gadolinium

Gadolinium

Gadolinium structure

Gadolinium 

structure

Description

metal foil, chunks or powder. The powder of gadolinium is highly flammable; incompatible with strong oxidising agents, halogens, acids; and reacts with water or moisture.


Liquid


Gadolinium(4+) is an elemental gadolinium and a monoatomic tetracation.|Gadolinium is under investigation in Hypertension, ACUTE KIDNEY INJURY, and Chronic Kidney Disease. Gadolinium has been investigated for the basic science of CAD, Multiple Sclerosis, and Coronary Artery Disease.|Gadolinium is an element with atomic symbol Gd, atomic number 64, and atomic weight 157.25.|An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.

Gadolinium Basic Attributes

157.25

157.924103

231-162-2

AU0V1LM3JT

DTXSID5037234

C39765

Silvery metal; hexagonal|Colorless or faintly yellowish metal; tarnishes in moist air

Characteristics

0

0.00000

Silver ingot

4.71 g/cm3

1313 °C (polymorph)

3273 °C(lit.)

3266°C

soluble in magnesium and diluted acid. Insoluble in water.

5.7X10-10 Pa at 1000 K; 1.54X10-6 Pa at 1200 K; 0.000429 Pa at 1400 K; 0.0279 Pa at 1600 K; 0.618 Pa at 1800 K; 7.39 Pa at 2000 K; 56.2 Pa at 2200 K (calculated)

The oxides are white. Curie Point = 292.7 °C, below which it becomes ferromagnetic.|Heat capacity: 37.03 J/mol K at 25 °C, 100 kPa|Heat of sublimation at 25 °C: 397.5 kJ/mol|Standard reduction potential (Gd3+/Gd): -2.28 V

Safety Information

III

8

UN 3208 4.3/PG 3

3

15-36/38

43-7/8-26-Neverusewater.

LW3850000

F,Xi

Stable. Powder is highly flammable. Incompatible with strong oxiziding agents, halogens, acids. Powder may react with water or moisture.

P231 + P232-P422

H261

The rare earth metals ignite in air at 302 to 356 °F, but lanthanum ignites at 824 to 860 °F. With oxide impurities present, however, the rare earth metals are pyrophoric on cutting and filing.|Rare earth metals burn vigorously in halogen vapors above 392 °F.

|Warning|H228 (19.61%): Flammable solid [Danger Flammable solids]|P210, P231+P232, P240, P241, P280, P370+P378, P402+P404, and P501|Aggregated GHS information provided by 62 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

IDENTIFICATION AND USE: Gadolinium is a silvery rare-earth metal. It is used as nuclear control rod material to capture thermal neutrons, to make gadolinium yttrium garnets, and to improve the workability and resistance of iron, chromium, and related alloys to high temperature and oxidation. HUMAN EXPOSURE AND TOXICITY: No information has been found. ANIMAL STUDIES: No information has been found.

The concentration of gadolinium in the earth's crust is 6.2 ppm(1). As a member of the lanthanide series ranging from atomic number 57 to 71, gadolinium does not occur in nature in the elemental state and the lanthanides always occur under their oxidized form in salts and minerals(1). Gadolinium-containing minerals include samarskite, gadolinite, xenotime, as well as other rare earth minerals(2). As gadolinium is found in nature, gadolinium compounds will be released to water and soils as a result of weathering of rocks and soil erosion(SRC).

Drug Information

... Gadolinium-153 ((153)Gd)-labeled gadopentetate (Magnevist), gadoteridol (ProHance), gadoterate (Dotarem), and gadodiamide (Omniscan) were administered iv to mice (0.48 mmol/kg) and rats (0.1 mmol/kg). At various times up to 14 days posttreatment, the residual 153Gd was measured in selected tissues. The tissue distributions obtained were used to make intra- and interchelate distribution evaluations and comparisons regarding tissue clearance and any possible in vivo dissociation of the Gd chelates. .... Differences were found among the chelates studied relative to the amounts of residual 153Gd present in tissues known to sequester free Gd, particularly in liver and femur at 7 and 14 days after administration, in both mice and rats. The pattern of the 153Gd distribution suggested that the linear chelates, gadopentetate and gadodiamide, dissociated in vivo resulting in more 153Gd present in bone and liver at the longer residence times than in the subjects injected with the macrocyclic chelates, gadoteridol and gadoterate. The only excipient found to affect the distribution profile was calcium(DTPA-BMA); this excipient in formulated gadodiamide decreased the amounts of residual Gd measured in whole body, bone, and liver in mice compared with levels obtained when gadodiamide was injected alone. ...

/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/|/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/|/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W TKO /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's (LR) if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/

Gadolinium

Gadolinium Use and Manufacturing

Methods of Manufacturing

(1) Reduction of the /gadolinium/ fluoride with calcium, (2) electrolysis of the /gadolinium/ chloride with sodium chloride or potassium chloride in an iron pot that serves as an anode and graphite cathode.

Uses

Used in atomic energy industry, used as magnetic materials, non-ferrous alloy additives Gadolinium has the highest thermal neutron capture cross section and can be used as a reactor control material and a structural material to prevent nuclear radiation. Gadolinium can also be used as an additive for new magnetic materials, yttrium iron garnet and yttrium aluminum garnet. Using gadolinium salt to cool by magnetization, ultra-low temperature close to absolute zero (0.002K) can be obtained. Gadolinium compounds can be used as the matrix material of phosphors, used to make X-ray intensifying screens and projection television devices. Used in the atomic energy industry, as an additive for magnetic materials and non-ferrous alloys

Ingots, lumps, turnings, powder up to 99.9+% pure.

Gadolinium: ACTIVE

Computed Properties

Molecular Weight:157.2
Exact Mass:157.92411
Monoisotopic Mass:157.92411
Heavy Atom Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Gadolinium

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.